ANTHRACYCLINE-INDUCED CARDIOTOXICITY
Clinical trials for ANTHRACYCLINE-INDUCED CARDIOTOXICITY explained in plain language.
Never miss a new study
Get alerted when new ANTHRACYCLINE-INDUCED CARDIOTOXICITY trials appear
Sign up with your email to follow new studies for ANTHRACYCLINE-INDUCED CARDIOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can exercise heal the hearts of childhood cancer survivors?
Disease control Not yet recruitingThis study aims to find out if exercise can help improve heart health in young adults who survived childhood cancer. It will compare two types of exercise training—high-intensity intervals versus moderate continuous workouts—to see which is more effective. About 20 participants w…
Matched conditions: ANTHRACYCLINE-INDUCED CARDIOTOXICITY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
Can a common cholesterol pill shield hearts from chemo damage?
Prevention Not yet recruitingThis study is testing whether the drug rosuvastatin can protect the heart from damage caused by a common type of breast cancer chemotherapy. 400 women starting this chemotherapy will take either rosuvastatin or a placebo pill daily for one year. The main goal is to see if the dru…
Matched conditions: ANTHRACYCLINE-INDUCED CARDIOTOXICITY
Phase: PHASE4 • Sponsor: Shiraz University of Medical Sciences • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC